EP3986572C0 - Kosmetische zusammensetzung mit einer kombination aus mindestens einem oligosaccharid und/oder polysaccharid, kombiniert mit einem mannosemonosaccharid sowie verwendung davon zur bewahrung des gleichgewichts der bakteriellen hautflora - Google Patents

Kosmetische zusammensetzung mit einer kombination aus mindestens einem oligosaccharid und/oder polysaccharid, kombiniert mit einem mannosemonosaccharid sowie verwendung davon zur bewahrung des gleichgewichts der bakteriellen hautflora

Info

Publication number
EP3986572C0
EP3986572C0 EP20733447.5A EP20733447A EP3986572C0 EP 3986572 C0 EP3986572 C0 EP 3986572C0 EP 20733447 A EP20733447 A EP 20733447A EP 3986572 C0 EP3986572 C0 EP 3986572C0
Authority
EP
European Patent Office
Prior art keywords
mannosemonosaccide
oligosaccharide
polysaccharide
balance
maintain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP20733447.5A
Other languages
English (en)
French (fr)
Other versions
EP3986572A1 (de
EP3986572B1 (de
Inventor
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67660378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP3986572(C0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP3986572A1 publication Critical patent/EP3986572A1/de
Application granted granted Critical
Publication of EP3986572B1 publication Critical patent/EP3986572B1/de
Publication of EP3986572C0 publication Critical patent/EP3986572C0/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20733447.5A 2019-06-24 2020-06-22 Kosmetische zusammensetzung mit einer kombination aus mindestens einem oligosaccharid und/oder polysaccharid, kombiniert mit einem mannosemonosaccharid sowie verwendung davon zur bewahrung des gleichgewichts der bakteriellen hautflora Active EP3986572B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1906838A FR3097436B1 (fr) 2019-06-24 2019-06-24 Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose
PCT/EP2020/067354 WO2020260201A1 (en) 2019-06-24 2020-06-22 Cosmetic composition comprising a combination of at least one oligosaccharide and/or polysaccharide combined with a mannose monosaccharide, and use thereof in maintaining the balance of the bacterial skin flora

Publications (3)

Publication Number Publication Date
EP3986572A1 EP3986572A1 (de) 2022-04-27
EP3986572B1 EP3986572B1 (de) 2025-11-19
EP3986572C0 true EP3986572C0 (de) 2025-11-19

Family

ID=67660378

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20733447.5A Active EP3986572B1 (de) 2019-06-24 2020-06-22 Kosmetische zusammensetzung mit einer kombination aus mindestens einem oligosaccharid und/oder polysaccharid, kombiniert mit einem mannosemonosaccharid sowie verwendung davon zur bewahrung des gleichgewichts der bakteriellen hautflora

Country Status (7)

Country Link
US (1) US20220233431A1 (de)
EP (1) EP3986572B1 (de)
JP (2) JP2022538560A (de)
KR (1) KR102811815B1 (de)
CN (1) CN113993596B (de)
FR (1) FR3097436B1 (de)
WO (1) WO2020260201A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3129083B1 (fr) * 2021-11-18 2024-09-27 Beghin Meiji Methode cosmetique et composition a base de fructo-oligosaccharides a chaine courte
FR3118711A1 (fr) * 2021-01-12 2022-07-15 Beghin Meiji Methode cosmetique et composition a base de fructo-oligosaccharides a chaine courte
AU2022207164A1 (en) * 2021-01-12 2023-07-06 Beghin Meiji Cosmetic method and composition based on short-chain fructooligosaccharides and a native starch
FR3125717B1 (fr) * 2021-07-30 2025-05-02 Oreal Composition comprenant au moins 0,5% en poids d’agent antioxydant, un lysat de Bifidobacterium species et un extrait de levure
FR3125714B1 (fr) * 2021-07-30 2025-03-07 Oreal Composition comprenant un agent antioxydant, un monosaccharide, un lysat de Bifidobacterium species et un extrait de levure
FR3125716B1 (fr) * 2021-07-30 2025-03-07 Oreal Procédé de traitement cosmétique comprenant l’application d’une composition comprenant au moins un agent anti-oxydant et un lysat de Bifidobacterium species
FR3125715B1 (fr) * 2021-07-30 2024-06-14 Oreal Composition comprenant un agent antioxydant, un ester d’acide gras particulier, un lysat de Bifidobacterium species et un extrait de levure
FR3133994A1 (fr) * 2022-03-30 2023-10-06 Roquette Freres Utilisation non thérapeutique de dextrines hyperbranchées comme agent apaisant.
WO2023193956A1 (fr) * 2022-04-05 2023-10-12 Roquette Freres Dextrines hyperbranchees hydrogenees pour preserver l'eubiose des microbiotes cutanes et des muqueuses
KR102457306B1 (ko) * 2022-04-14 2022-10-21 주식회사 루씨베이전씨 피부 개선 및 장 기능 개선 효과가 있는 유산균을 포함하는 건강기능식품 조성물 및 이의 제조방법
KR102842819B1 (ko) * 2022-10-07 2025-08-06 코스맥스 주식회사 만노스를 포함하는 화장료 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
US7507402B1 (en) * 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
JP2001131029A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
FR2863887B1 (fr) * 2003-12-23 2008-05-16 Jean Noel Thorel Procede d'innoformulation d'une base galenique biocompatible
FR2874825B1 (fr) * 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
HUP0500582A1 (hu) * 2005-06-13 2007-08-28 Csaba Jozsef Dr Jaszberenyi Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok
FR2916634B1 (fr) * 2007-06-01 2009-10-02 Jean Noel Thorel Association synergique vis-a-vis de la flore microbienne de l'epiderme humain et applications cosmetiques et pharmaceutiques
WO2010000578A2 (en) * 2008-06-09 2010-01-07 Nestec S.A. Use of honeybush or honeybush extracts with prebiotics for skin and hair
FR2954140A1 (fr) * 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
WO2013122931A2 (en) * 2012-02-14 2013-08-22 The Procter & Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
FR3009962B1 (fr) * 2013-08-28 2018-02-23 Laboratoire Herasens Compositions a base de prebiotiques et d'extraits de curculigo orchioides et leurs utilisations
EP2929873A1 (de) * 2014-04-07 2015-10-14 Intermed S.A. Hautreinigungszusammensetzungen
FR3030253B1 (fr) * 2014-12-18 2018-03-02 Nutricos Technologies Composition pour ameliorer l'aspect cellulitique de la peau
US9925137B2 (en) * 2015-08-19 2018-03-27 Maple Mountain Group, Inc. Skin rejuvenation and defense system
WO2018098152A1 (en) * 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017365025A1 (en) * 2016-11-23 2019-07-11 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
IT201600130012A1 (it) * 2016-12-22 2018-06-22 Neilos S R L Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale
FR3064473B1 (fr) 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
US10695386B2 (en) 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
CN107412045A (zh) 2017-05-19 2017-12-01 广州蜜妆生物科技有限公司 一种益生元健肤面膜
CN109106644A (zh) * 2018-09-27 2019-01-01 广州航美化妆品有限公司 美白修护霜

Also Published As

Publication number Publication date
FR3097436A1 (fr) 2020-12-25
CN113993596B (zh) 2025-03-14
FR3097436B1 (fr) 2023-10-13
JP2024028358A (ja) 2024-03-04
WO2020260201A1 (en) 2020-12-30
JP2022538560A (ja) 2022-09-05
EP3986572A1 (de) 2022-04-27
EP3986572B1 (de) 2025-11-19
KR20220024863A (ko) 2022-03-03
CN113993596A (zh) 2022-01-28
US20220233431A1 (en) 2022-07-28
KR102811815B1 (ko) 2025-05-22

Similar Documents

Publication Publication Date Title
EP3986572C0 (de) Kosmetische zusammensetzung mit einer kombination aus mindestens einem oligosaccharid und/oder polysaccharid, kombiniert mit einem mannosemonosaccharid sowie verwendung davon zur bewahrung des gleichgewichts der bakteriellen hautflora
PH12018500029A1 (en) Microbiome-compatible cosmetics
EP4483953A3 (de) Kosmetische mischungen
MX2016014623A (es) Composiciones de combustible.
SA517381998B1 (ar) تركيبة لتضميد الجرح
AR090186A1 (es) Control de microorganismos fitopatogenicos con pseudomonas sp. y sustancias y composiciones derivadas de las mismas
MX2015010260A (es) Composicion que comprenden un agente de control biologico y un fungicida.
EP4527208A3 (de) Flüssige zusammensetzung mit phycocyanin
EP3474861A4 (de) Zusammensetzungen mit hmos, deren herstellung und verwendung zur prävention und/oder behandlung von viralen und/oder bakteriellen infektionen
MX2017011711A (es) Mejora en o con relacion a compuestos organicos.
BR112021020240A2 (pt) Composições fungicidas
WO2019069035A3 (fr) Composition de rouge a levres d'aspect mat
EP3890492A4 (de) Verfahren zur herstellung und verwendung von pflanzen und pflanzenteilen mit erhöhtem nährstoff-, öl- und/oder proteingehalt
CL2021000173A1 (es) Composiciones para la agricultura y métodos relacionados.
MX2016010389A (es) Composiciones de combustible.
EP3607961A4 (de) Verwendung eines pflanzenextrakts zur herstellung einer zusammensetzung zur erhöhung der expression von tgm1-, krt-, aqp3-, flg-, gba- und has-genen
MX2018003086A (es) Composicion que tiene residuo reducido.
MX2018014621A (es) Composicion biopesticida para uso en la prevencion o para minimizar la enfermedad de la planta.
ATE548310T1 (de) Spaltfreudiges klebeband, seine verwendung und verwendung eines werkzeuges zu seiner herstellung
KR20180084612A (ko) 맞춤형 화장품 제조방법 및 시스템
WO2019035089A3 (en) Lectin-bound bacteria and uses thereof
EP3923924A4 (de) Nicht-racemische beta-hydroxybutyrat-verbindungen und mit dem r-enantiomer angereicherte zusammensetzungen und verfahren zur verwendung
EA201591206A1 (ru) Композиции для личной гигиены, содержащие глазированный сахар
BR112012026544A2 (pt) plantas com biossíntese alterada da parede celular e métodos de uso
MX2017015575A (es) Lamina con un aspecto de tipo madera.

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: L'OREAL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20241126

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250801

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: F10

Free format text: ST27 STATUS EVENT CODE: U-0-0-F10-F00 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20251119

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20251119

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

Effective date: 20251125